APA (7th ed.) Citation

Y, A., N, Q., A, A., K, A., & MA, Y. (2026). Management of splenomegaly in patients with myelofibrosis in the era of JAK inhibitors: A comprehensive review. Frontiers in oncology, 16, 1851781. https://doi.org/10.3389/fonc.2026.1851781

Chicago Style (17th ed.) Citation

Y, Al-Asa'd, Qasem N, Alshurafa A, Al-Farsi K, and Yassin MA. "Management of Splenomegaly in Patients with Myelofibrosis in the Era of JAK Inhibitors: A Comprehensive Review." Frontiers in Oncology 16 (2026): 1851781. https://doi.org/10.3389/fonc.2026.1851781.

MLA (9th ed.) Citation

Y, Al-Asa'd, et al. "Management of Splenomegaly in Patients with Myelofibrosis in the Era of JAK Inhibitors: A Comprehensive Review." Frontiers in Oncology, vol. 16, 2026, p. 1851781, https://doi.org/10.3389/fonc.2026.1851781.